Hope for Rare Liver Disease: New Drug Offers Relief to Young Girl in Montreal

A nine-year-old girl in Montreal is experiencing a significant improvement in her quality of life thanks to a newly approved medication for a rare liver disease. Mélody, who has been battling the condition since birth, is being treated at CHU Sainte-Justine.

Understanding Progressive Familial Intrahepatic Cholestasis

Mélody suffers from progressive familial intrahepatic cholestasis (PFIC), a genetic disorder that impairs the liver’s ability to process bile. This buildup of bile causes severe itching and can lead to liver damage. “I scratch myself until I bleed,” Mélody shared with Noovo Info.

How PFIC Affects the Liver

According to Dr. Marie-Ève Chartier, a pediatric hepatologist at CHU Sainte-Justine, PFIC occurs when the transporters responsible for moving bile out of the liver don’t function properly. This leads to bile accumulation, causing symptoms like intense itching, and jaundice. “At birth, Mélody was yellow,” Dr. Chartier explained.

A Rare and Challenging Condition

PFIC is considered an orphan disease, affecting approximately one in 50,000 to one in 100,000 people. This rarity means research into effective treatments has been limited.

New Drug Offers Hope

After four months on the new medication, recently approved by Health Canada, Mélody is showing remarkable improvement. The treatment is significantly reducing her itching and improving her sleep, something she has struggled with since birth. “We can already see that at the skin level, she no longer has any lesions and she sleeps much better,” Dr. Chartier noted.

Avoiding Liver Transplant

Traditionally, children with PFIC often require a liver transplant before adulthood. However, CHU Sainte-Justine is hopeful that this new medication will help Mélody avoid the necessitate for a transplant. “It gives a lot, a lot, a lot of hope,” said Providence Loranger, Mélody’s mother, emphasizing the importance of continued research.

Access to Treatment

Mélody is currently receiving the medication through a compassionate access program, but it is expected to be reimbursed by the Régie de l’assurance maladie du Québec (RAMQ) in the coming months.

You can identify more information about Mélody’s story in this YouTube video from Noovo Info.